Omer Jamy is currently an associate professor of medicine in the Division of Hematology/Oncology at the University of Alabama at Birmingham, USA. He completed his MD at Aga Khan University in 2012 and his internal medicine residency at the University of Tennessee in Memphis, followed by fellowship training in hematology/oncology and bone marrow transplantation and cellular therapy at the University of Alabama at Birmingham. His clinical and research interests include myeloid malignancies (acute myeloid leukemia, myelodysplastic syndrome, chronic myeloid leukemia and myelofibrosis), acute lymphoblastic leukemia and allogeneic stem cell transplantation.
Omer Jamy is currently an associate professor of medicine in the Division of Hematology/Oncology at the University of Alabama at Birmingham, USA. He completed his MD at Aga Khan University in 2012 and his internal medicine residency at the University of Tennessee in Memphis, followed by fellowship training in hematology/oncology and bone marrow transplantation and cellular therapy at the University of Alabama at Birmingham. His clinical and research interests include myeloid malignancies (acute myeloid leukemia, myelodysplastic syndrome, chronic myeloid leukemia and myelofibrosis), acute lymphoblastic leukemia and allogeneic stem cell transplantation.